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Abstract 
 
Objective: To scope the literature describing misophonia populations, management, and 
research opportunities. 
Method: Literature searches for research studies describing patients diagnosed with 
misophonia, defining a patient profile, or outlining, developing, or testing an intervention for. 
A data extraction for was developed and piloted before data from each article were 
independently charted by two researchers. Researchers then agreed a final dataset for each 
article.   
Results: Thirty-one records were included. The misophonia population was described in 
terms of onset age, triggers, reaction, coping strategies, and comorbid conditions. We 
identified nine outcome measures. Case studies on treatments included Cognitive 
Behavioural Therapy, Counterconditioning, Mindfulness and Acceptance, Dialectical 
Behavioural Therapy and pharmaceuticals. Future research priorities identified included 
clarifying the phenomenology and prevalence of misophonia, and randomized controlled 
trials of treatments. 
Conclusion: Misophonia is under researched but there are strong foundations for future 
research to finalize diagnostic criteria, validate outcome measures, and trial treatments. 
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Introduction 
 
Misophonia, literally meaning hatred of sound, was first referred to in research 
literature in 2002 to describe a consistent set of symptoms and has since been increasingly 
encountered by clinicians (Jastreboff & Jastreboff, 2002; 2003; Bernstein, Angell & Dehle 
2013; McFerran 2016; Kumar et al., 2017).The initial definition of misophonia was ‘an 
abnormally strong reaction occurring to a sound with a specific pattern and/or meaning to an 
individual’ (Jastreboff & Jastreboff, 2014).  Typically, patients suffer a strong negative 
emotional and autonomic ‘fight or flight’ reaction triggered by specific sound stimuli termed 
‘trigger sounds’ (Edelstein, Brang, Rouw, & Ramachandran 2013; Jastreboff & Jastreboff, 
2013; Schröder, Vulnik & Denys 2013b; Wu, Lewin, Murphy & Storch 2014). Although 
variations exist, most commonly the patient experiences a disproportionate level of hate, 
anger, rage, and disgust towards a person producing sounds associated with eating (e.g. 
chewing, swallowing) or breathing (Edelstein et al., 2013). The symptoms usually occur 
irrespective of sound spectrum and intensity and are exacerbated within a familar context 
(Edelstein et al., 2013). An important exception is self-produced similar sounds which have 
the same spectrum and intensity but do not usually evoke these abnormal reactions. Disturbed 
by the inappropriateness of his or her reaction, the patient engages in maladaptive coping 
mechanisms such as avoiding social situations in which the trigger-sounds might occur. 
Ultimately this results in interpersonal and occupational impairment, anxiety, and obsessive 
compulsions. Patients with severe misophonia suffer from the intrusive and unwanted 
preoccupation with trigger-stimuli, as well as compulsive stress-reducing and avoidance 
behaviours (Cavanna & Seri, 2015; Webber & Storch, 2015) which are typically seen in 
patients with  obsessive compulsive disorder (OCD) (Bruxner, 2016). Moreover, these 
reactions are in some cases equally evoked by repetitive visual person-related triggers (e.g. 
leg-rocking or watching somebody chew) termed misokinesia, suggesting the disorder 
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expands beyond merely audiological symptoms, and confirming a strong likeness to OCD as 
well as Tourette syndrome. Other less frequent comorbid conditions include mood disorder, 
panic disorder, attention deficit hyperactivity disorder, hypochondria, trichotillomania, and 
skin picking. (Schröder et al. 2013b; Taylor, Conelea, McKay, Crowe & Abramowitz 2014; 
Ferreira, Harrison & Fontenelle 2013; Hazen et al., 2008; Johnson et al., 2013; McGuire, Wu 
& Storch 2015; Taylor et al., 2014; Webber, Johnson & Storch 2014).  
 
Misophonia has, of yet, no official diagnostic formulation within the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) or the International Statistical 
Classification of Diseases and Related Health Problems, 10th revision (ICD-10) (Kumar et 
al., 2017). Considering the parallels to OCD, it has been proposed that misophonia can be 
categorized within the obsessive compulsive spectrum of disorders in the DSM-V (Schröder 
2013b). On the other hand, as it borders both psychiatry and audiology, misophonia is also 
considered to be categorizable with disorders in audiology including tinnitus (perception of 
constant internally-perceived abstract sounds), hyperacusis (discomfort/pain experienced due 
to everyday sounds of a normal or louder intensity), phonophobia (extreme fear towards 
specific trigger sounds). Misophonia is distinct from these disorders although there is some 
overlap in symptoms and an individual may present with more than one condition (Jastreboff 
2000; Jastreboff and Jastreboff 2003; Fackrell et al., 2017; Schwartz, Leyendecker, & Conlon 
2011). 
Currently, little is known about the aetiology of misophonia (Jastreboff and Jastreboff 2014). 
Propositions of the psychiatric nature of misophonia (Ferreira et al., 2013) are founded on the 
basis that it is not an auditory disorder caused by a neurological dysfunction. This is 
evidenced as misophonia patients typically have normal hearing thresholds (Schröder et al., 
2013b). Instead, misophonia is associated with an increased number of connections, or 
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strength of connections, between the limbic and sympathetic nervous systems which can 
cause abnormal processing of sound stimuli (Moller, 2011; Jastreboff & Hazell, 2008; 
Jastreboff & Jastreboff, 2013). Case studies also suggest a hereditary component in 
misophonia (Cavanna 2014).  
 
Treatments for misophonia include Tinnitus Retraining Therapy and sound therapy 
(Jastreboff and Jastreboff 2013, Formby, Sherlock & Gold 2003) and Cognitive Behavioural 
Therapy (CBT) (Schröder et al., 2017; Bernstein et al., 2013; McGuire et al., 2015; Reid, 
Guzick, Gernand & Olsen 2016). Other less documented cognitive treatments for misophonia 
include Counterconditioning (Dozier 2015a), applied relaxation (Martz 2013), and the intake 
of serotonergic or anti-dopaminergic agents, which have been shown to have some efficacy 
on misophonia when it is within an OCD diagnosis (Neal & Cavanna 2013; Eddy & Cavanna 
2013).  
 
Rationale for the review 
The research literature has noted a steady increase in the number of misophonia cases over 
the last decade (Wu et al., 2014; Schwartz et al., 2011; Hadjipavlou, Baer, Lau & Howard 
2008). Consequently, there has also been a rise in the number of relevant research studies 
(Duddy & Oeding 2014), gradually compiling an evidence base for this new and independent 
condition. A point has now been reached where the literature on misophonia needs to be 
catalogued purposefully to provide an account of the current research position and guide 
future research priorities. This review on misophonia is the first to apply a scoping review 
methodology to the subject. 
 
Aims 
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This scoping review aimed to collate the research evidence to date on the definition, patient 
profile, assessment, and treatment of misophonia, such that research gaps and opportunities 
could be identified. Specifically, our objectives relate to (1) how misophonia and the 
populations it affects are described in research literature, (2) what research has been 
conducted to date on the assessment and treatment of misophonia, and (3) in both cases, what 
are priority research questions. 
 
Methods 
 
This review is reported according to the PRISMA checklist extension for scoping reviews 
(PRISMA-ScR; Tricco et al., 2018). No protocol for the review was published. A 
methodological framework for scoping reviews was followed (Arksey & O’Malley 2005, 
Levac, Colquhoun, & O’Brien 2010; Peters et al., 2015; Khalil et al., 2016) involving six 
stages whereby (1) the purpose and research questions were defined, (2) relevant studies were 
identified using a three-step literature search in order to balance the breadth and 
comprehensiveness, (3) studies were selected using an iterative team approach to study 
selection and data extraction, (4) the data were charted incorporating qualitative thematic 
analysis where necessary, (5) the results were collated, summarized and reported, including 
the implications for policy, practice or research, and (6) the findings were reviewed by 
clinical experts in the field who did not take part in stages 1-5. 
 
Eligibility criteria 
Records were included if they (1) reported research studies (including studies of aetiology, 
symptomatology/patient profiles, prevalence, incidence, cohort and case control studies) and 
focused on describing the population of patients diagnosed with misophonia, or (2) reported 
case studies, case series, cohort, feasibility or pilot studies where the purpose was to define a 
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patient profile or outline or develop an intervention for patients with a primary complaint of 
misophonia, or (3) reported randomized controlled trials (RCTs), non-RCT, case or cohort 
studies or case series where the effectiveness of an intervention for misophonia was tested 
and misophonia was the primary complaint or part of a symptom set. 
 
Records were excluded if they were not peer reviewed, were reviews (our searches confirm 
there are no previous related scoping or systematic reviews), were personal/expert opinions 
and editorials, manuals or guidelines, patents, not available in English, or were reporting 
animal studies.   
 
Information sources and search strategy 
Initial searches were conducted in July 2016. Searches were conducted in Embase, 
PsychINFO, PubMed CENTRAL, Scopus, Web of Science, Cochrane CENTRAL, Cochrane 
Ear Nose and Throat Disorders Group Trials Register, Clinical Trials.gov, the International 
Standard Randomized Controlled Trial Number registry (ISRCTN), the International Clinical 
Trials Registry Platform (ICTRP), Cumulative Index to Nursing and Allied Health Literature 
(CINAHL PLUS) and Google Scholar. We applied a specific search term strategy in each 
search engine (Table 1), searching in article topics, titles, abstracts, and keywords. Where 
possible, filters were applied to retrieve articles in the English language and with human 
participants only. There was no restriction in the search period. Table of contents of the most 
common journals (determined using the interquartile rule for outliers) and the reference lists 
of any relevant review articles identified throughout the process which had misophonia in the 
title, were also screened. Searches were last updated in June 2018. 
 
[INSERT TABLE 1 ABOUT HERE] 
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Study Selection  
Using an iterative approach, all abstracts were assessed independently by two researchers as 
meeting the review criteria or not. Records were first screened by title and abstract and in the 
next stage by full text. There were no disagreements between authors regarding the inclusion 
or exclusion of a record for this review. 
 
Data extraction 
A data extraction form was created in Excel and was piloted by two reviewers on two records 
before finalising. Data were then extracted independently by two reviewers (IP and DH) 
according to the following items: First Author; Year of Publication; Title of study; 
Publication Type; Publication type: other; Country study aim; Misophonia definition; Study 
design; Methods; If combination methods we specified; Sample size; percentage of 
participants with misophonia; Study population ; Setting; Age; Gender; Misophonia primary 
or secondary complaint; Age at onset; Trigger sounds; Response to the trigger sounds; 
Aggressive reaction use menu; Coping mechanisms; Other co-morbidities; Assessment time 
points; Eligibility screening methods; Assessments/ Outcome measures; Treatment aimed 
primarily at misophonia; Nature of therapeutic intervention (components); Main outcomes of 
study - empirical; Main outcomes of study - anecdotal; Study limitations; Further research; 
Notes. Disagreement on the extracted data was minimal and generally related to omissions 
rather than errors. Where these occurred both authors revisited the record to agree a final 
dataset. The final datasets were then charted by topic according to the aims of the review, 
namely the definition, patient profile, assessment (diagnosis and measurement), and treatment 
of misophonia. We additionally catalogued research priorities nominated in the literature.    
 
Results 
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Figure 1 displays the flow of records identified, screened, included, or excluded, with reasons 
for exclusion. Thirty-one records were included in this review; 17 were case studies or case 
series, six were non-randomized controlled trials, two were online surveys and six were 
cohort studies. The earliest study was published in 2008 and one third of them were published 
in 2017. Fourteen studies were conducted in the US, eight in the Netherlands, two in 
Australia, two in the UK, two in Brazil, one in China, one in Turkey, and one in Canada. Six 
studies included children (aged under 18 years old) only, 17 studies included adults only, and 
six studies had a mixed population. Two studies could not be classified according to age as 
only mean sample ages were reported. Further study details are available in Supplementary 
materials 1 and 2. 
 
[INSERT FIGURE 1 ABOUT HERE] 
 
Definitions of misophonia  
Common terminology was observed in most definitions of misophonia used in the literature. 
Most commonly it was described as a disproportionately extreme, aversive, and irrational 
emotional reaction (Bernstein et al., 2013; Boyce 2015; Colucci 2015; Dozier 2015a,b; 
Edelstein et al., 2013; Kumar et al., 2014; Webber et al., 2014; Kumar et al., 2017; Erfanian, 
Brout & Keshavarz. 2017, Tunç & Başbuğ 2017; Vidal et al., 2017; Schneider & Arch 2017; 
McKay et al., 2017; Sanchez & de Silva 2017; Rouw & Erfanian 2017) to specific (Boyce 
2015, Colucci 2015, Edelstein et al., 2013, Giorgi et al., 2015; Webber et al., 2014; Reid et 
al., 2016; Wu et al., 2014; Tunç & Başbuğ 2017; Schröder, Vulink, van Loon & Denys 2017; 
Vidal, Vidal, & Lage 2017; Schneider & Arch 2017; McKay, Kim, Mancusi, Storch & 
Spankovich 2017; Sanchez & de Silva 2017; Rouw & Erfanian 2017) common human 
innocuous sounds (Dozier 2015b,c; Johnson et al., 2013; Schröder et al., 2013a; Schröder, 
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San Giorgi, Van Wingen, Vulink & Denys 2015; Kumar et al; 2017, Schröder et al., 2017; 
Schneider & Arch.,2017) and sometimes animal sounds (Schneider & Arch 2017). Some 
authors described in detail the eliciting stimuli of this reaction. Two authors mentioned in 
their definitions the term ‘trigger sounds’ (Dozier 2015a; Webber et al., 2014) and some 
explained what these were exactly: breathing, wheezing, chewing, eating, slurping, lip 
smacking, pen clicking/tapping, typing, or cracking knuckles (Schröder et al., 2013a;2014; 
2015; 2017; Kumar et al., 2017; Schneider & Arch 2017; Sanchez & de Silva 2017; McKay 
et al., 2017). Two authors (Hadjipavlou et al., 2008; Wu et al., 2014) described misophonia as 
a condition of decreased sound tolerance and six authors mentioned selective sound 
sensitivity syndrome (4S) as a synonym of misophonia (Kluckow, Telfer & Abraham 2014; 
Webber et al., 2014; McGuire et al., 2015; Wu et al., 2014; Sanchez & de Silva 2017; Zhou, 
Wu & Storch 2017). The literal meaning of misophonia, hatred of sound, was used in the 
definition provided by some authors. (Edelstein et al., 2013; Kumar et al., 2014; Giorgi 2015; 
Schröder et al., 2013b; Wu et al., 2014). 
 
Most authors described emotional reactivity, commonly experienced by patients, as part of 
their working definition. It is reported that emotional reactions “range or escalate” (Dozier 
2015a) from discomfort (Wu et al., 2014), anxiety, distress (Johnson et al., 2013; Wu et al., 
2014) to irritation, disgust, hate, anger, and loss of self-control (Boyce 2015; Colucci 2015, 
Dozier 2015a,b,c; Kumar et al., 2014; Giorgi 2015; Schröder et al., 2013a; Schröder et al., 
2015; Webber et al., 2014, Reid et al., 2016; Wu et al., 2014; Kumar et al., 2017; Schröder et 
al., 2017). Some authors also referred to aggressive outbursts as a central hallmark of the 
condition (Schröder et al., 2013a; Schröder et al., 2014; Webber et al., 2014; McGuire et al., 
2015; Kluckow et al., 2014; Tunç & Başbuğ 2017). In addition to an emotional reaction, 
some authors referred to physiological or autonomic arousal (in terms of a trigger) in their 
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definitions of misophonia (Bernstein et al., 2013; Edelstein et al., 2013; Vidal et al., 2017). 
Some definitions also noted the presence of coping mechanisms, typically avoidance 
strategies (Kumar et al., 2014; Schröder et al., 2015; Webber et al., 2014; McGuire et al., 
2015; McKay et al., 2017).  
 
The misophonia population  
Onset  
Almost all studies which reported onset age of misophonia found that symptoms emerged in 
childhood (Dozier 2015a,b,c; Johnson et al., 2013) or adolescence (i.e. up to 18 years of age) 
(Hadjipavlou et al.,2008; Kumar et al., 2014; Bernstein et al., 2013; Johnson et al., 2013; 
Kluckow et al., 2014; McGuire et al., 2015; Reid et al.,2016; Schröder et al., 2013b; Kamody 
& Del Conte 2017; Schneider & Arch 2017).  Two studies reported that the onset was in 
adulthood (i.e. 18 years and over) (Boyce 2015; Tunç & Başbuğ 2017) and two studies 
reported an onset age that can spread over the lifespan (Sanchez & de Silva 2017; Zhou et al., 
2017). 
 
Triggers and context 
Person-related sounds reported to trigger misophonic responses included oral sounds, 
especially those made by people eating, such as chewing, lip smacking, swallowing noises, 
and throat noises (Boyce 2015; Colucci 2015; Dozier 2015b; Hadjipavlou et al., 2008; Kumar 
et al., 2014; Schröder et al., 2015; 2017; Bernstein et al., 2013; Dozier 2015a,c; Johnson et 
al., 2013; Reid et al., 2016;  Schröder et al., 2013b; Schröder et al., 2014; Wu et al., 2014; 
Kumar et al., 2017; Vidal et al; 2017; Schneider & Arch 2017; Sanchez & de Silva 2017; 
Zhou et al., 2017; Tunç & Başbuğ 2017; Kamody & Del Conte 2017), nasal sounds, such as 
breathing, blowing nose, sniffling, coughing (Dozier 2015a; Schröder et al., 2015; Dozier 
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2015c; Johnson et al., 2013; Schröder et al., 2013b; Schröder et al., 2014; Wu et al.,2014; 
Kumar et al., 2017; Sanchez et al., 2017; Zhou et al., 2017; Kamody & Del Conte 2017), and 
in single cases, nail picking (Hadjipavlou et al., 2008) or sneezing (Dozier 2015c). Specific 
spoken sounds, such as /s/, /t/, /ch/, /k/ (Colucci 2015; Wu et al., 2014), or consonants and/or 
vowels (Zhou et al., 2017) and specific voices (Boyce 2015; Hadjipavlou et al., 2008; 
Webber et al., 2014) were also reported as triggers. The context in which the triggers are 
experienced also appears important. Authors observed that triggers experienced within a 
familiar context, i.e. a family, friends, and occupational, or educational setting were more 
likely to cause a stronger misophonia reaction (Dozier 2015b; Edelstein et al., 2013; 
Bernstein et al., 2013; Dozier 2015a,c; Johnson et al., 2013; Kluckow et al., 2014; McGuire 
et al., 2015; Boyce 2015; Edelstein et al., 2013; Schneider & Arch 2017). 
 
Other common trigger-sounds include repetitive clicking and tapping (Colucci 2015; Johnson 
et al., 2013; McGuire et al., 2015; Reid et al., 2016; Schröder et al., 2014; Wu et al., 2014; 
Vidal et al., 2017; Zhou et al., 2017), or sounds produced by using utensils, keys, or ice in a 
glass (Dozier 2015b, c; Johnson et al., 2013; Sanchez & de Silva 2017). Individual cases also 
describe bird chirps (Dozier 2015b; Johnson et al., 2013), dog barking (Kluckow et al., 2014; 
Sanchez & de Silva, 2017), rustling (Schröder et al., 2014; Sanchez & de Silva 2017; Zhou et 
al., 2017), and conversations in Spanish in a Hispanic individual who spoke both Spanish and 
English, as triggers (McGuire et al., 2015).  
 
In some cases (Dozier 2015a,b; Hadjipavlou et al., 2008; Schröder et al., 2014; Vidal et al., 
2017), triggers included person-related visual stimuli accompanying the  auditory stimuli 
such as swinging arms or legs, jiggling, or rubbing hands together, which can fall under the 
term misokinesia. 
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The misophonic reaction 
All authors describe the misophonic reactions of their participants as various combinations of 
discomfort, distress, anxiety, annoyance, disgust, panic, extreme irritation, anger, hate, or 
sometimes rage with aggressive outbursts or involuntary violence (Colucci 2015; Dozier 
2015b, Edelstein et al., 2013; Hadjipavlou et al., 2008; Webber et al., 2014; Kumar et al., 
2014; Bernstein et al., 2013; Schröder et al., 2013b, 2017; Dozier 2015a,c; Johnson et al., 
2013; Kluckow et al., 2014; McGuire et al., 2015; Reid et al., 2016; Kumar et al., 2017;Vidal 
et al., 2017; Schneider and Arch 2017; Sanchez and de Silva 2017; Rouw & Erfanian 2017; 
Tunç & Başbuğ 2017; Kamody & Del Conte 2017 ). A larger qualitative study based on 42 
people with misophonia (Schröder et al., 2013b) reports that physical aggression was present 
as a reaction in five of them. A physical reaction to trigger sounds appeared common and 
included contraction, tension, or sensation in specific muscles (Dozier 2015a,b,c; Bernstein et 
al., 2013; Kluckow et al., 2014; Kamody & Del Conte 2017); and/or heavy breathing 
(Kluckow et al., 2014; McGuire et al., 2015). Edelstein et al., (2013) stated that the most 
common reaction reported in their sample was pressure experienced in the chest, arms or 
head, muscle tension, or a ‘fight or flight’ reaction (i.e. an autonomic stress response). One 
single case was noted to experience intrusive images of mouths and urges to mimic this 
(Hadjipavlou et al., 2008); another described feelings of shame and remorse (Bernstein et al., 
2013). 
 
Coping strategies 
Patients managed their symptoms through avoidance behaviour e.g. leaving the situation, 
wearing earphones, or avoiding situations where the trigger might occur including quitting 
work (Edelstein et al., 2013; Kumar et al., 2014; Webber et al. 2014; Boyce 2015; Colucci 
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2015; Dozier 2015a,b,c; Hadjipavlou et al., 2008; Johnson et al., 2013; Kluckow et al., 2014; 
McGuire et al., 2015; Reid et al., 2016; Schröder et al., 2013b; Schneider and Arch 2017; 
Kamody & Del Conte 2017). Other strategies included confrontation i.e. demanding the 
offender (e.g. family member) to stop producing the trigger sound (Dozier 2015a,b; Webber 
et al., 2014; Edelstein et al., 2013; Johnson et al., 2013; Kluckow et al., 2014; Reid et al., 
2016; Sanchez and de Silva 2017); also mimicking the offensive sound  (Edelstein et al., 
2013; Hadjipavlou et al., 2008; Schröder et al., 2013b), engaging in a positive internal 
dialogue (Edelstein et al., 2013, Kluckow et al., 2014; Reid et al., 2016), or distracting 
themselves from the sound (Kluckow et al., 2014) by producing anti-sounds (Schröder et al., 
2013b) or diverting their thoughts (Schröder et al., 2017). Two single cases reportedly 
managed their symptoms using muscle relaxation exercises (Dozier 2015b). One case 
restrained herself from aggressive verbal outbursts by keeping her mouth full of food at meal 
times (Kluckow et al., 2014). 
 
Comorbid conditions 
Misophonia was noted to be co-morbid with OCD (Webber et al., 2014; Johnson et al., 2013; 
Kluckow et al., 2014; Reid et al., 2016; Schröder et al., 2013b; 2017, Wu et al., 2014; 
Erfanian et al., 2017), depression (Dozier 2015a; Johnson et al., 2013; Reid et al., 2016; Wu 
et al., 2014; Schroder et al., 2017; Erfanian et al., 2017), attention deficit hyperactivity 
disorder (ADHD) (Reid et al., 2016; Schröder et al., 2013b; 2014; 2017), asthma (Dozier 
2015a,b; Kluckow et al., 2014), Tourette Syndrome (Wu et al. 2014; Schröder et al., 2013b; 
2017), dysthymic disorder (Schröder et al., 2017; Erfanian et al., 2017); eating disorders 
(Kluckow et al., 2014; Schröder et al., 2017), post-traumatic stress disorder (PTSD) (Dozier 
2015b; Erfanian et al., 2017); social phobia (Hadjipavlou et al., 2008; Erfanian et al., 2017); 
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body dysmorphic disorder (Hadjipavlou et al.,2008; Schröder et al., 2017) and panic disorder 
(Hadjipavlou et al., 2008; Erfanian et al.,2017).  
 
Individual cases were also reported that had borderline personality disorder (Boyce 2015), 
tinnitus and hearing loss (Colucci 2015), specific phobia (Reid et al., 2016), agoraphobia 
(Erfanian et al., 2017), generalized anxiety disorder (Dozier 2015c), Kawasaki disease 
(Johnson et al., 2013), hypochondria (Schröder et al., 2013b), skin picking (Schröder et al., 
2013b; 2017), and bipolar disorder (Schröder et al., 2013b; 2017). It is important to note that 
although these various conditions were present alongside misophonia there is no evidence as 
yet to suggest any association. A future study should examine the prevalence of these 
comorbid conditions to evaluate which, if any, are in fact more prevalent in people with 
misophonia. 
 
Neurobiological findings 
Six records included neurobiological data from patients with misophonia. Edelstein et al. 
(2013) and Kumar et al. (2017) measured skin conductance during exposure to a range of 
trigger sounds in people with misophonia and healthy controls. They found that those with 
misophonia assign higher aversion, distress, and annoyance ratings, and have higher skin 
conductance or galvanic skin responses to auditory but not visual stimuli.  
 
Giorgi (2015) used fMRI to explore brain areas involved in the misophonia reaction. They 
found hyperactivation in the bilateral auditory cortex and the left amygdala in patients with 
misophonia when exposed to misophonia triggers but not when the stimuli were neutral. 
Another fMRI experiment by Schröder et al. (2015) also found increased activity in the 
auditory cortex and the left amygdala. Schröder et al. (2013a) measured the mismatch 
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negativity response - an objective test of automatic central auditory processing, finding it to 
be reduced in patients with misophonia compared to controls outside of any audiological 
distortions. The most recent work in this area (Kumar et al., 2017) suggests that misophonia 
is directly associated with an abnormal function of the anterior insular cortex (AIC) and a 
network of regions responsible for processing and regulation of emotions including 
ventromedial prefrontal cortex, posteromedial cortex, hippocampus, and amygdala. Kumar et 
al. (2017) also found that triggers elicited heightened heart rate and galvanic skin response in 
misophonia subjects, which were mediated by AIC activity. Questionnaire data indicated that 
patients with misophonia had higher interoceptive sensibility than controls, consistent with 
abnormal functioning of anterior insular cortex. Brain structural measurements implied 
greater myelination within ventromedial prefrontal cortex (vmPFC) in misophonic 
individuals. 
 
Schröder et al. (2014) used EEG and an oddball paradigm to measure auditory event-related 
potentials (ERPs) evoked by pure tones between patients with misophonia and control 
participants. They found that the mean amplitude of the auditory N1, a marker linked to early 
attention and detection of abrupt sensory changes, was significantly diminished in patients 
with misophonia. Notably though, their patient group exhibited a higher total mood 
disturbance score than the controls which, the authors suggest, may reflect a general state of 
hyperarousal in patients’ emotional state. 
 
Prevalence 
Two studies provide some prevalence data on misophonia. Wu et al. (2014) reported that in 
their sample of 483 undergraduate students 20% were classed as having clinically significant 
misophonia symptoms that cause interference in their lives. Another study with a sample size 
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of 415 also suggested a prevalence rate of 20% of ‘often’ or ‘always’ experiencing sound 
sensitivity to triggers. However, this rate dropped to 6% for significantly interfering 
misophonia symptoms (Zhou et al., 2013).  Kluckow et al. (2014) reported that, in a sample 
of 15 patients with eating disorders three also had misophonia, as determined from the 
Amsterdam Misophonia Scale (A-Miso-S) (Schröder et al., 2013b) and the Misophonia 
Activation Scale (MAS-1) (Fitzmaurice 2010). 
 
Diagnosis and measurement  
Most studies used an unstructured clinical interview to assess misophonia (Dozier 2015b, 
Hadjipavlou et al., 2008, Bernstein et al., 2013; Reid et al., 2016, Boyce 2015, Edelstein et 
al., 2013; Kamody & Del Conte 2014; Giorgi 2015; Webber et al., 2014; Johnson et al., 2013; 
Kluckow et al., 2014; Schröder et al., 2013b; 2017; Vidal et al; 2017; Schneider and Arch 
2017; Sanchez and de Silva 2017). Three studies specified use of the structured clinical 
interview for DSM IV Axis I or Axis II to diagnose patients with misophonia (Bernstein et 
al., 2013; Schröder et al., 2013b; Tunç & Başbuğ 2017), and one used the M.I.N.I. 
International Neuropsychiatric Interview for the diagnosis of affective disorders (Erfanian et 
al., 2017). 
 
Different questionnaire measures of misophonia severity were used across studies. The most 
commonly used was the Amsterdam Misophonia Scale (A-Miso-S; Schröder et al., 2013b) 
(Reid et al., 2016; Giorgi 2015; Schröder et al., 2015; 2017; Kluckow et al., 2014; Schröder 
et al., 2013b; Schröder et al., 2014; Schneider and Arch 2017; Rouw and Erfanian 2017; 
Tunç & Başbuğ 2017; Kamody & Del Conte 2017) which is based on the Yale Brown 
Obsessive Compulsive Scale (Y-BOCS). Dozier (2015a,b) used the Misophonia Assessment 
Questionnaire (MAQ) and the Misophonia Coping Responses Survey (MCR) which, 
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anecdotally, were both proposed by audiologist Marsha Johnson, although no information is 
available to verify this or how the questionnaires were developed. Dozier (2015b,c) used the 
Misophonia Trigger Severity Scale (MTS) by Natan Bauman (no  reference identified). 
Kluckow et al. (2014) and Dozier (2015b) used the Misophonia Activation Scale – MAS-1 
(Fitzmaurice 2010). The Misophonia Physiological Scale (MPS) was used by Dozier 2015c 
and has been developed by Natan Bauman (no reference identified).  
 
The most recently published questionnaires are the Misophonia Emotional Response (MER; 
Dozier et al., 2015 b, c), and the Misophonia Questionnaire (MQ; Wu et al., 2014) (also used 
in, McGuire et al., 2015; Dozier 2015b; McKay et al., 2017; Zhou et al., 2017). The 
Misophonia Severity Scale (MSS), a sub-scale of the MQ, was adapted from the NIMH 
Global Obsessive-Compulsive Scale (NIMH GOCS; Murphy, Pickar & Alterman, 1982). The 
MSS was used in two other studies (Dozier 2015b; McGuire et al., 2015). None of the 
available questionnaires have been yet been subjected to formal psychometric evaluation. 
 
Treatments approaches for misophonia 
Twelve studies explored treatments for misophonia. Three studies investigated a CBT method 
(McGuire et al., 2015; Bernstein et al., 2013; Schröder et al., 2017). In one study, a CBT sub-
type called Exposure and Response Prevention (ERP) was documented for a patient with a 
primary complaint of OCD (Reid et al., 2016). Three studies investigated counterconditioning 
treatment (Dozier et al., 2015 a,b,c). One study used mindfulness and acceptance to treat 
misophonia (Schneider & Arch, 2017) and one used Dialectical Behaviour Therapy (DBT) 
(Kamody & Del Conte 2017). One study (Hadjipavlou et al., 2008) documented two cases 
treated with a combination of exposure therapy, relaxation, and medication. Three studies 
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(McGuire et al., 2015; Vidal et al., 2017; Tunç & Başbuğ 2017) reported the results of using 
medication alone to treat misophonia. 
 
Bernstein et al., (2013) described a case where CBT treatment comprised of challenging 
dysfunctional automatic thoughts, and a behavioural component to interrupt and substitute 
maladaptive and avoidant coping strategies with helpful ones. These included redirecting 
attention and talking openly with people producing the triggers in a non-offensive manner. 
There was also a physiological component involving exercise before meals to recalibrate 
autonomic reactivity. At the end of treatment, the case still found chewing noises unpleasant, 
but the triggers no longer impaired her social or occupational functioning and this effect was 
maintained at a 4-month follow-up assessment.  
 
In McGuire et al. (2015) CBT included psychoeducation and achieving “habituation” through 
a combination of exposure and cognitive restructuring. More specifically, the two cases were 
exposed to triggers titrated upward in frequency and intensity to habituate them to the distress 
caused by the triggers. The process was then switched from the therapist to family members. 
To restructure dysfunctional beliefs about the triggers, cognitive restructuring was practiced 
during the exposures. Relapse prevention strategies were also introduced towards the end of 
treatment. Both cases showed improvement in misophonia symptoms based on their scores 
on the MQ and MSS, and anecdotal patient reports.  
 
Schröder et al. (2017) tested an adaptation of group CBT on 90 patients. Components 
included task concentration exercises to train patients to shift their attention to neutral stimuli 
during exposures; counterconditioning was also used to break the association patients had 
between trigger sounds and experiencing negative emotions. Stimulus manipulation was the 
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third component in this therapy. Patients were taught how to assume a sense of control over 
their responses by manipulating the trigger sounds they exposed themselves to on a computer 
at home as part of homework. Relaxation exercises were also included to help patients 
manage feeling of anger and rage, on the assumption that misophonia patients’ irritability is 
related to an increased general arousal. This version of therapy significantly reduced 
misophonia symptoms in nearly half of patients and was found especially useful for more 
severe cases of misophonia. 
 
Reid et al. (2016) investigated a single patient who had misophonia and comorbid OCD, 
depression, and specific phobia. In this case only two of the 14 sessions of CBT Exposure 
Relapse Prevention (CBT ERP) treatment were aimed at managing the misophonia problem. 
CBT ERP involved working with the patient through imaginal and in-vivo exposures to the 
stimulus. The structure of the two sessions for misophonia were not specified in the study so 
it is unclear whether these two sessions used ERP to treat the misophonia symptoms or 
whether it was standard CBT. The two misophonia sessions occurred in the middle of 
treatment for OCD. The patient also completed two related homework sessions. At the end of 
treatment, this patient’s misophonia reduced from severe to mild/subclinical based on her A-
Miso-S score, and this improvement was maintained at 3-month follow-up. 
 
Schneider & Arch (2017) applied mindfulness and acceptance methods to treat misophonia in 
one case. Components were derived from Acceptance and Commitment Therapy (ACT) 
(acceptance, mindfulness, diffusion, and values) and DBT (acceptance, mindfulness, 
“nonjudgmentalness”, and opposite action) perspectives, although several techniques could 
also be conceptualized from a classic CBT perspective (e.g., identifying the link between 
thoughts, feelings, and behaviours). Treatment consisted of 10 x 50-min sessions. Specific 
21 
 
techniques included diffusion exercises (being aware of one's thoughts to create distance 
between the patient and the thoughts rendering them less overwhelming); DBT-style chain 
analyses to compare situations eliciting stronger and weaker reactions. A component of 
removing judgement was also included where the patient practiced noticing his judgmental 
thoughts and re-describing the situation objectively (just the facts). This method was effective 
2 months later, and 6 months post-treatment, whereby the patient’s scores across all measures 
including the A-Miso-S and Y-BOCS continued to decrease. The patient was better able to 
accept and tolerate the discomfort triggered by his misophonia. 
 
Dialectical Behaviour Therapy (DBT) was used in one case (Kamody & Del Conte, 2017) 
suffering comorbid anxiety and misophonia. DBT sessions were weekly for 7 weeks. The 
essence of the treatment was to acquire DBT skills of mindfulness and distress tolerance; to 
understand one’s ability to transact differently with the environment despite his/her 
predisposition to anger, find alternative strategies to dealing with anger and guilt, and reduce 
behavioural engagement in behavioural urges. During treatment the patient was also given 
paroxetine hydrochloride (an SSRI) of 25 mg (no frequency given) to simultaneously manage 
misophonic and anxiety symptoms. The authors reported a symptom reduction from severe to 
mild based on the A-Miso-S.  
 
“Exposure therapy” was investigated in two cases (Hadjipavlou et al., 2008). The authors did 
not give information as to what the “exposure therapy” constituted, or whether it was part of 
CBT. This kind of therapy had limited effects in both cases due to non-compliance and 
perceived lack of benefit. The authors reported that alongside “exposure therapy” the two 
cases also received medication and relaxation treatment – although it is unclear if it was 
simultaneous. In the first case, the selective serotonin reuptake inhibitors (fluoxetine; dose 
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not specified) combined with relaxation techniques provided symptomatic relief.  In the other 
case, a 25-year-old woman with multiple morbidities, antidepressants, anxiolytics, 
antipsychotics, stimulants, and mood stabilizers were all ineffective, as were sound 
generators. McGuire et al. (2015) reported that a regimen of venlafaxine (150mg/day) (a 
serotonin-norepinephrine reuptake inhibitor) and lisdexamfetamine (70mg/day) (a central 
nervous system stimulant) led to moderate improvement in misophonia symptoms. However, 
the case had still suffered significant functional impairment and subsequently received CBT 
treatment. 
 
Counterconditioning is a treatment which involves the pairing of a powerful, positive 
stimulus with a conditioned trigger stimulus causing the conditioned reflex to cease or die 
out. This method was specifically adapted to treat misophonia, and was tested in three studies 
(Dozier 2015a,b,c). It involves multiple treatment sessions in which a low intensity, short 
duration trigger stimulus was intermittently provided during a continuous positive stimulus 
such as music. Patients were encouraged to practice muscle relaxation during the treatments 
and to complete homework sessions using appropriate devises. Two studies testing this 
methodology were case studies, and one was a case series. Anecdotal patient reports suggest 
some improvement in patient symptoms; no empirical data were provided.  
 
Two studies used medication alone to treat misophonia. Vidal et al. (2017) report on a single 
case of misophonia and obsessional symptoms treated with escitalopram (SSRI) (no dose 
detail given). Evaluation after 30 days showed partial relief from misophonia symptoms. In 
Tunç & Başbuğ (2017) a case was treated with alprazolam (a benzodiazepine) (0.5 mg/day) 
for three days to which the patient had responded well although misophonia persisted. 
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Research priorities nominated in the literature  
Suggestions for future research on misophonia in the literature included the need to confirm 
the phenomenology and prevalence of misophonia (Hadjipavlou et al., 2008), and its genetic 
and neurological mechanisms (Edelstein et al., 2013; Hadjipavlou et al., 2008; Webber et al., 
2014; Dozier 2015a; Schröder et al., 2014; Giorgi 2015: McKay et al., 2017; Tunç & Başbuğ 
2017). Edelstein et al. (2013) also suggests investigating the natural history of misophonia 
and the evolution of triggers over time. There are also suggestions for further research into 
hereditary factors in misophonia (Sanchez and de Silva, 2017; Rouw and Erfanian 2017) and 
its comorbidties (Erfanian et al., 2017). There appears to be a consensus that conducting 
RCTs of the available treatments for misophonia is urgent (Dozier 2015b,c; Edelstein et al., 
2013; Hadjipavlou et al., 2008; Reid et al., 2016; Schröder et al., 2017; Schneider and Arch 
2017; Kamody & Del Conte 2017). Dozier (2015b) proposed that a set of validated 
assessment instruments for misophonia should be established. The effectiveness of CBT and 
how it links with brain responses was specifically suggested (Giorgi 2015; McGuire et al., 
2015; Reid et al., 2016). Finally, investigating misophonia within certain populations (i.e. 
paediatric, autism spectrum disorder, eating disorders, and tinnitus) in order to garner a better 
clinical picture of misophonia, and to clarify its association with tinnitus, was mentioned by a 
number of authors (Wu et al., 2014; Kluckow et al., 2014; McGuire et al., 2015; Zhou et al., 
2017).  
 
Discussion 
 
This scoping review catalogues the research describing misophonia, its population, methods 
of assessment, treatments, and future research priorities. Inherent to scoping review 
methodology, we included all the relevant and available research studies on misophonia 
treatments. We found that most studies used methodologies that provide low level evidence, 
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with over half of the current research on misophonia taking the form of case studies. This 
finding highlights the need for controlled studies and clinical trials on misophonia. 
 
Misophonia is a condition only described as such in the last two decades and no official 
diagnostic criteria have yet been formulated. Although Schröder et al. (2013b) proposed a set 
of diagnostic criteria, this has not been formalised. We scoped the available definitions of 
misophonia used by researchers, and found a high level of common terms and statements. 
Still some definitions were broad and did not seem to differentiate misophonia from 
hyperacusis. The collation of definitions presented here can be used in finding consensus on a 
single definition and description of misophonia. It also serves as a starting point to consider 
the validity of existing or new misophonia measurement questionnaires. These measures will, 
in turn allow more rigorous diagnostic profiling and evaluation of available treatments for 
misophonia.  
 
Descriptions of the misophonia population consistently identified that its onset is in 
childhood or early adolescence at 12 or 13 years. There can also be individual cases where  
misophonia begins in childhood up or middle-age. As reported in a previous review (Bruxner 
et al., 2015) the triggers of the misophonia symptoms are almost always produced by 
humans, and most commonly involve oral and nasal sounds, with the level of familiarity of 
the context within which the triggers are experienced playing a significant role. Over the 
course of their condition some patients can develop intolerance to certain visual stimuli 
which accompany the audible ones, such as movement of mouths, and these can become 
triggers on their own. A few studies also report that repetitive noises such as clicking and 
tapping can also trigger misophonia symptoms. This suggests a possible continuum between 
misophonia and misokinesia (hatred of movement) (Schröder et al., 2013b). Misokinesia is 
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not currently known to exist as a discrete condition but is rather a less common misophonia 
symptom. 
 
Evidence on the prevalence of misophonia is only available from two student populations. 
Authors report a rate of 20% of people ‘often’ or ‘always’ experiencing sensitivity to triggers 
with 6% experiencing impairment. This could mean that while many may experience sound 
sensitivity to some triggers, a relatively low percentage suffer. 
 
Few studies have been dedicated so far to studying the neurological correlates of misophonia. 
Of those conducted most used MRI or EEG and skin conductance. The findings are all 
considered preliminary but consistently suggest that misophonia involves abnormal 
functioning of the amygdala, an area of the brain commonly associated with negative 
emotions, aversive learning, and processes of attention and vigilance (Davidson & Irwin 
1999; Davis & Whalen 2001; Holland & Gallagher 1999). The most recent study reported 
here (Kumar et al., 2017) provides further evidence that it is the AIC and its connection to the 
amygdala, and other regions involved in emotion, that are malfunctioning in patients with 
misophonia. Currently it is still unclear whether the AIC malfunction is a cause or 
consequence of misophonia. The study found that patients also displayed a generally 
heightened baseline emotional state or hyperarousal, though there was evidence too that they 
had a lowered automatic central auditory processing mechanism. Further research is required 
to confirm these findings and how they link to the aetiology, progress, and maintenance of 
misophonia. 
 
Some of the cases we reviewed could potentially be classed as being ‘extreme’ and not 
representative of the typical misophonia population. However the current evidence base on 
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the symptomatology of misophonia cannot differentiate these for certain. On the whole we 
found that the misophonic reaction frequently reported in research involves intense negative 
feelings which can vary from anxiety, disgust, panic, discomfort, annoyance, frustration, and 
rage, with the latter reported as a key characteristic (Schröder et al., 2013; 2014; Dozier 
2015a,b,c; Kumar et al., 2014). Patients may experience anxiety in anticipation of hearing the 
trigger sounds and then anger and disgust when they actually hear them. The literature we 
reviewed suggests that the dominant misophonia reaction involved intense negative feelings 
(Schröder et al., 2013b; 2014; Dozier 2015a,b,c; Kumar et al., 2014; 2017) but also anxiety or 
fear of being unable to control the intolerance (Edelstein 2013; Hadjipavlou et al., 2008; 
Kumar et al., 2014). Research also showed that the misophonic reaction is commonly 
associated with muscle tension in various body regions, symptoms related to anxiety 
(Sainsbury & Gibson 1954; Ginsburg, Riddle & Davies 2005), as well as abnormal physical 
stress (Rouw & Erfanian 2017). In line with this, Wu et al. (2014) and Zhou et al. (2017) 
found that it is indeed anxiety which mediates the link between sound intolerance and anger 
outbursts. This idea is also supported by the model proposed by Webber and Storch (2015) 
highlighting the central role of anxiety which is negatively reinforced by behavioural 
responses, and sheds light on the treatment of misophonia. Therefore, it appears that although 
anger is the dominant misophonic reaction, anxiety caused by the anger, affects the 
consequent behavioural responses such as intrusive compulsions or safety behaviours. These 
behavioural consequences may lead to interpersonal and occupational dysfunction (Schwartz 
et al. 2011; Cavanna 2014) causing decreased quality of life which, in turn causes more 
anxiety. Further highlighting the role of anxiety in misophonia we found that the condition 
most commonly reported to be comorbid with misophonia was the anxiety disorder OCD. 
Schröder et al. (2013b) highlighted that both disorders share the intrusive and unwanted 
preoccupation and compulsive stress-reducing and avoidance behaviours. For this reason, he 
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has proposed that misophonia could be classified within the obsessive compulsive spectrum 
of disorders of the DSM-IV. The parallels between misophonia and OCD also informed the 
development of the A-MISO-S and the MSS. However, the psychometric properties of these 
two measures, as well as other less commonly used outcome measures for misophonia, are 
yet to be established.  
 
Evidence on effective treatments for misophonia is scarce. Less than half of the available 
studies on misophonia focused on treatment, and all but one were case studies. Hence in 
reviewing, one must be conscious of the potential ‘file drawer effect’, whereby only cases of 
effective treatment get published. The most researched type of treatment for misophonia was 
CBT in various adaptations, whereby achieving habituation to the triggers through in-vivo 
exposures, was the common component amongst them. These proved effective in all studies, 
as did counterconditioning (a type of behavioural treatment where controlled exposure to 
triggers to achieve habituation is also central but lacks the cognitive counselling element of 
CBT). Although these positive findings are based on anecdotal reports, there is a good 
foundation to conduct RCTs to ascertain the most effective format of CBT treatment. Other 
cognitive treatments such as mindfulness and acceptance and DBT also showed promising 
results and warrant further research. Certain medication, such as fluoxetine, venlafaxine, 
lisdexamfetamine, paroxetine hydrochloride, escitalopram, and alprazolam were used either 
in combination with a cognitive therapy or alone. Future research should compare and assess 
the exact effect of these drugs on misophonia. It is crucial to highlight that although such 
medication has been tested with misophonia patients this does not amount to evidence of 
effectiveness. RCTs are required to assess the safety dosages and whether or not they are 
effective. Currently only one clinical trial on the neural and self-reported effect of CBT has 
been identified as ongoing (ISRCTN:12571777). 
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Limitations 
Firstly, although this is a review of misophonia research, the definitions of misophonia used 
in the included records are varied and so the participants and patients described may not 
represent a homogenous population. Secondly, although we undertook the optional Stage 6 
(consultation) of scoping reviews (Levac et al., 2010), there is a current lack of guidance on 
how this is best conducted.  We chose to incorporate the clinicians’ interpretations of the 
results from their experience within the discussion section. A more systematic process of 
conducting and reporting the consultation stage could enhance the value of this stage of the 
scoping review process.  
 
Conclusion 
Although no formal nosology of misophonia has yet been finalized, research to date shows 
consistency in terms of the characteristics of misophonia that are described. To date, there are 
no studies that provide a reliable estimate of the prevalence of misophonia in the general 
population, nor in specific patient populations. Demographic data would inform the true scale 
of the disorder and better define the scale of need for healthcare. Nevertheless research in 
misophonia has progressed in the last decade in that outcome measures of misophonia have 
been developed and some possible treatments have been shown effective in providing relief 
in case studies. Authors in the field agree the need for studies that validate existing outcome 
measures, RCTs of treatments, and studies to determine the aetiology and natural history of 
misophonia. The current evidence base on misophonia is not yet substantial enough to 
consider a systematic review. However, we suggest that RCTs testing possible treatments for 
misophonia is a vital next step for patients. Epidemiological research and consensus-based 
research is necessary for demographic estimations and to ascertain diagnostic criteria. 
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